(Q46473465)

22 December 2017

title

Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma (English)

1 reference

22 December 2017

1 reference

Brian J Lipworth

1

1 reference

22 December 2017

Michael A Kaliner

2

1 reference

22 December 2017

Craig F LaForce

3

1 reference

22 December 2017

James W Baker

4

1 reference

22 December 2017

Harold B Kaiser

5

1 reference

22 December 2017

Dilip Amin

6

1 reference

22 December 2017

Sudeep Kundu

7

1 reference

22 December 2017

James E Williams

8

1 reference

22 December 2017

Renate Engelstaetter

9

1 reference

22 December 2017

Donald D Banerji

10

1 reference

22 December 2017

publication date

1 April 2005

1 reference

22 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

22 December 2017

volume

94

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

465-472

1 reference

22 December 2017

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Adrenal suppression with inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Safety of inhaled and intranasal corticosteroids: lessons for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961117-9

7 January 2021

10.1016/S1081-1206(10)61117-9

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017